FDA Import Refusal 799-5338587-9/11/1 — Boehringer Ingelheim Canada
The FDA refused shipment 799-5338587-9/11/1 from Boehringer Ingelheim Canada (Canada) on Jun 29, 2023. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 29, 2023
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75